# US 2012/0251449 A1 · Aldh: a compound for cancer stem cell imaging

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0251449 A1
- Document ID: US20120251449A1
- Status: Published application
- Kind: A1
- Application number: 13/510,398
- Filed: 2010-12-22
- Published: 2012-10-04
- Earliest claimed: 2009-12-22
- Inventors: Vijaya Raj Kuniyil Kulangara; Alan Cuthbertson; Peter Iveson; Chitralekha Rangaswamy; Veena Rao; Rajiv Bhalla
- Web page: https://patentgrep.com/patent/US20120251449A1

## CPC

- A61K 31/136: having the amino group directly attached to the aromatic ring, e.g. benzeneamine
- A61K 51/04: Organic compounds
- A61P 35/00: Antineoplastic agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention claims fluoro- & iodo-containing aldehydes as ALDH substrates for use as diagnostic imaging agents or as therapeutic agents. The aldehydes are both directly and indirectly attached to an aromatic or a straight chain ring. ALDH activity was monitored either by the formation of acid-product or consumption of aldehyde substrates.

## Claims

### Claim 1

A compound for tumor stem cell imaging of ALDH in vivo wherein the compound is a radionuclide of formula I comprising:
A—Ar—NH—Cn—CH═O (I)
wherein A is 18F or 123I, Ar is a 6- or 8-carbon member-ring or a 6-, 8-, 10-, or 12-member aliphatic chain ring, or a fused polycyclic ring and n is 1-4.

### Claim 2

A compound for tumor stem cell imaging of ALDH in vivo wherein the compound is a radionuclide of formula II comprising:
A—Ar—CH═O (II)
wherein A is 18F or 123I, Ar is a 6- or 8-carbon member-ring or a 6-, 8-, 10-, or 12-member aliphatic chain ring, or a fused polycyclic ring.

### Claim 3 (depends on 1)

A pharmaceutical composition comprising an effective amount of a compound of formula (I) according to claim 1, or a salt thereof, together with one or more pharmaceutically acceptable adjuvants, excipients or diluents for use in enhancing image contrast in in vivo imaging or for treatment of a disease.

### Claim 4 (depends on 2)

A pharmaceutical composition comprising an effective amount of a compound of formula (II) according to claim 2, or a salt thereof, together with one or more pharmaceutically acceptable adjuvants, excipients or diluents for use in enhancing image contrast in in vivo imaging or for treatment of a disease.

### Claim 5

(canceled)

### Claim 6 (depends on 1)

A method of generating images of a human or animal body involving administering a compound of formula I according to claim 1 to said body, and generating an image of at least a part of said body to which said contrast agent has distributed.

### Claim 7 (depends on 1)

A method of generating enhanced images of a human or animal body comprising a compound as claimed in claim 1, which method comprises generating an image of at least part of said body.

### Claim 8 (depends on 3)

A method of monitoring the effect of treatment of a human or animal body with a drug to combat a condition associated with cancer, said method involving administering to said body a composition as claimed in claim 3 and detecting the uptake of said composition by cell receptors, said administration and detection optionally but preferably being effected repeatedly, e.g. before, during and after treatment with said composition.

### Claim 9 (depends on 3)

A method of treating cancer or a related disease in a human or animal body which comprises the administration of an effective amount of a composition as claimed claim 3.

### Claim 10

(canceled)

### Claim 11 (depends on 2)

A method of generating images of a human or animal body involving administering a compound of formula II according to claim 2 to said body, and generating an image of at least a part of said body to which said contrast agent has distributed.

### Claim 12 (depends on 4)

A method of monitoring the effect of treatment of a human or animal body with a drug to combat a condition associated with cancer, said method involving administering to said body a composition as claimed in claim 4 and detecting the uptake of said composition by cell receptors, said administration and detection optionally but preferably being effected repeatedly, e.g. before, during and after treatment with said composition.

### Claim 13 (depends on 4)

A method of treating cancer or a related disease in a human or animal body which comprises the administration of an effective amount of a composition as claimed claim 4.
